Renal Replacement Therapy

Introduction

End-stage renal disease (ESRD) is a common term used for patients in CKD stage 5 (GFR <15 ml/minute/1.72m2). These patients may require renal replacement therapy such as

  • Dialysis
  • Renal transplant



Dialysis

The principle of dialysis is simple. The patient's blood and a dialysis solution are positioned on opposing sides of a semi-permeable membrane across which exchange of metabolites occurs.

The 2 primary types of dialysis are haemodialysis (HD) and peritoneal dialysis (PD).

  • Neither has been shown to be superior to the other in any particular patient group.
  • The choice of dialysis mode is made based on the patients' concomitant diseases, preferences and socioeconomic factors.



Factors Affecting Drug Removal During Dialysis

When a patient receives dialysis, the pharmacist must consider the amount of medication cleared during dialysis in order to recommend the correct dose and interval.

  • Medications that are removed during dialysis must be given after dialysis or may require a supplemental dose following dialysis.

Factors affecting drug removal during dialysis

  • Drug characteristic
    • Molecular size - Smaller molecules are more readily removed.
    • Volume of distribution - Drugs with a large Vd are less likely to be removed.
    • Protein-binding - Highly protein-bound drugs are less likely to be removed.
  • Dialysis factors
    • Membrane - High-flux (large pore size) and high-efficiency (large surface area) HD filters removes more substances than conventional/low-flux filters.
    • Blood flow rate - Higher dialysis blood flow rates increase drug removal over a given time interval.



Renal Transplantation

One of the major challenges for renal transplantation is identification of a sufficient number of donor kidneys to fulfil demand.

Immunosuppressive drugs are used to control the response as the immune system of the recipient mount against the donor kidney (i.e. alloimmunity).

  • Due to their relative non-specificity, the patients are exposed to an increased risk of malignancy and infection, which is an important cause of morbidity and mortality.
Mechanism of Action of Immunosupperssants



External Links

Comments